RZRan Zhao

Ran Zhao

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ran Zhao has a total of 51 co-authors. Here are the top co-authors by number of shared publications:

  • Dongbei Guo

    State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Innovation Platform for Industry-Education Integration in Vaccine Research, School of Public Health, Xiamen University, No. 4221-117 South Xiang'an Road, Xiang'an District, Xiamen 361102, Fujian, People's Republic of China

    4 shared publications
  • Guangshun Wang

    State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Innovation Platform for Industry-Education Integration in Vaccine Research, School of Public Health, Xiamen University, No. 4221-117 South Xiang'an Road, Xiang'an District, Xiamen 361102, Fujian, People's Republic of China

    3 shared publications
  • Hao Xu

    State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Innovation Platform for Industry-Education Integration in Vaccine Research, School of Public Health, Xiamen University, No. 4221-117 South Xiang'an Road, Xiang'an District, Xiamen 361102, Fujian, People's Republic of China

    3 shared publications
  • Qiuying An

    State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Innovation Platform for Industry-Education Integration in Vaccine Research, School of Public Health, Xiamen University, No. 4221-117 South Xiang'an Road, Xiang'an District, Xiamen 361102, Fujian, People's Republic of China

    3 shared publications
  • Xiaoxuan Chen

    State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Innovation Platform for Industry-Education Integration in Vaccine Research, School of Public Health, Xiamen University, No. 4221-117 South Xiang'an Road, Xiang'an District, Xiamen 361102, Fujian, People's Republic of China

    3 shared publications
  • Chun Fan

    State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, Xiamen University, Xiamen, China

    2 shared publications

Latest Publications

  • Open Access

    Exploration of risk analysis and elimination methods for a Cr(VI)-removal recombinant strain through a biosafety assessment in mice

    by Wanting You, Qiuying An, Dongbei Guo, Zebo Huang, Lulu Guo, Zigui Chen, Hao Xu, Guangshun Wang, Yeting Weng, Zhangye Ma, et al.


  • Open Access

    Aerobic Degradation Characteristics of Decabromodiphenyl ether through Rhodococcus ruber TAW-CT127 and Its Preliminary Genome Analysis

    by Hao Xu, Qingtao Cai, Qiuying An, Chen Tang, Wanpeng Wang, Guangshun Wang, Wanting You, Dongbei Guo, Ran Zhao

    Decabromodiphenyl ether (BDE-209), a polybrominated diphenyl ether (PBDE) homolog, seriously threatens human health. In this study, a Rhodococcus ruber strain with high BDE-209 degradation activity, named TAW-CT127, was isolated from Tong’an Bay, Xiamen. Under laboratory conditions, the strain’s optimal growth temperature, pH, and salinity are 45 °C, 7.0, and 0–2.5%, respectively. Scanning electron microscopy (SEM) analysis shows that TAW-CT127 is damaged when grown in manual marine culture (MMC) medium with BDE-209 as the sole carbon source instead of eutrophic conditions. In the dark, under the conditions of 28 °C, 160 rpm, and 3 g/L (wet weight) TAW-CT127, the degradation rate of 50 mg/L BDE-209 is 81.07%. The intermediate metabolites are hexabromo-, octabromo-, and nonabromo-diphenyl ethers. Through whole-genome sequencing, multiple dehalogenases were found in the genome of TAW-CT127; these may be involved in the production of lower-brominated diphenyl ethers. Additionally, biphenyl-2,3-dioxygenase (BDO) in TAW-CT127 may catalyze the debromination reaction of BDE-209. Our research provides a new high-efficiency strain for bioremediation of BDE-209 pollution, and lays the foundation for the preliminary exploration of genes associated with BDE-209 degradation.


  • Open Access

    Cr(VI) Removal by Recombinant Escherichia coli Harboring the Main Functional Genes of Sporosarcina saromensis M52

    by Qiuying An, Min Zhang, Dongbei Guo, Guangshun Wang, Hao Xu, Chun Fan, Jiayao Li, Wei Zhang, Yi Li, Xiaoxuan Chen, et al.

    Hexavalent chromium [Cr(VI)], a recognized heavy metal pollutant, has attracted much attention because of its negative impact on the ecological environment and human health. A chromium-resistant strain, Sporosarcina saromensis M52, was discovered, and the functional genes orf2987, orf3015, orf0415, and orf3237 were identified in the strain by genomics. With the advancement of DNA recombination and gene-splicing technology, genetic engineering technology was used to produce recombinant strains 2987, 3015, 0415, and 3237. The study revealed Cr(VI) tolerance in the order of M52 ≈ 2987 > 3015 ≈ 0415 > 3237 and reduction abilities in the order of M52 ≈ 2987 > 3015 > 0415 ≈ 3237. SEM-EDS, XRD, FT-IR and XPS were utilized to examine the surface structure of the recombinant strains and analyze the surface components and main functional groups. A comprehensive review of the recombinant strains’ capacity to tolerate and reduce Cr(VI) revealed that orf2987 and orf0415 were the main functional genes in Sporosarcina saromensis M52, which may play a key role in removing Cr(VI) and protecting the strain, respectively. The optimum pH for recombinant strains 2987 and 0415 was 7.5–8.5, and the optimum temperature was 37°C. Cu2+ had the greatest promotional effect when Cr(VI) was removed by them, while SDS had an inhibitory effect. This research provided the foundation for further study into the mechanism of Cr(VI) reduction in Sporosarcina saromensis M52, as well as a theoretical basis for the development of effective engineered strains to repair Cr(VI) contamination.


  • Open Access

    Exploring the Cr(VI) removal mechanism of Sporosarcina saromensis M52 from a genomic perspective

    by Jiayao Li, Chen Tang, Min Zhang, Chun Fan, Dongbei Guo, Qiuying An, Guangshun Wang, Hao Xu, Yi Li, Wei Zhang, et al.


  • Identification of Boseongicola sediminum sp. nov., a Novel Decabromodiphenyl Ether (BDE-209)-tolerant Strain Isolated from Coastal Sediment in Xiamen, China

    by Chen Tang Chen, Chun Fan Chun, Dong Bei Guo Dong Bei, Xiu Juan Ma Xiu Juan, Qing Tao Cai Qing Tao, Xiao Xuan Chen Xiao Xuan, Min Zhang Min, Jia Yao Li Jia Yao, Qiu Ying An Qiu Ying, Ran Zhao Ran


  • Seafood consumption among Chinese coastal residents and health risk assessment of heavy metals in seafood

    by Ran Zhao, Shuangshuang Yan, Min Liu, Bi Wang, Dong Hu, Dongbei Guo, Juan Wang, Wanting Xu, Chun Fan

    The aims of the present study were to obtain the seafood dietary patterns of coastal residents, to determine the concentrations of heavy metals, and to evaluate the possible health risks caused by seafood intake. The daily food intakes of 24 types of seafood were collected from 738 participants from Xiamen, a southern Chinese coastal city, using food frequency questionnaire (FFQ) and dietary history method. One hundred and fifty-six samples of 14 types of highest intake seafood were collected from local markets for lead (Pb), cadmium (Cd), chromium (Cr), mercury (Hg), and arsenic (As) determination. Health risks via seafood consumption were evaluated by calculating the target hazard quotient (THQ) and the total hazard index (HI) for carcinogenic and non-carcinogenic effects recommended by the US Environmental Protection Agency. The results showed that the seafood daily intake of Xiamen residents was 61.5 (2.14, 115) g/day. The concentrations of Pb, Cd, Cr, Hg, and As in seafood were ND–0.45 mg/kg, ND–0.19 mg/kg, ND–0.80 mg/kg, ND–0.70 mg/kg, and 0.32–16.9 mg/kg, respectively. Concentrations of Cd and As in some samples were higher than national limitation standards. Consumption of 14 common types of seafood would not pose non-carcinogenic risk. However, some types, such as sparuslatus, oyster, and porphyra tenera, would form a carcinogenic risk. Regardless of a carcinogenic or non-carcinogenic risk, As posed the highest risk on humans. The observed HI value for non-carcinogenic effect of all metals in all seafood reached 0.69–2.20, and the metal orders of risk can be listed as As > Hg > Cr > Cd > Pb, reiterating the risk of As is a matter of concern in seafood from Xiamen markets.


  • Open Access

    Protein phosphatase 2A-B55δ enhances chemotherapy sensitivity of human hepatocellular carcinoma under the regulation of microRNA-133b

    by Qunying Zhuang, Tengjian Zhou, Chengyong He, Shili Zhang, Yang Qiu, Bing Luo, Ran Zhao, Hengchuan Liu, Yuchun Lin, Zhongning Lin

    Hepatocellular carcinoma (HCC) remains a major public health problem worldwide. The identification of effective chemotherapeutic targets for advanced HCC patients is urgently required. In this study, we investigated the role of protein phosphatase 2A-B55δ subunit (PP2A-B55δ, encoded by the PPP2R2D gene) and related mechanisms affecting chemotherapy sensitivity of HCC. Experimental approaches for measuring the levels of PPP2R2D mRNA and B55δ protein in HCC included bioinformatics analyses, quantitative real-time polymerase chain reaction (qRT-PCR), western blotting (WB), immunofluorescence and immunohistochemistry assays. Cell cycle, migration, colony formation, apoptosis, and cell proliferation assays in stable PPP2R2D-knockdown and -overexpression cell lines in vitro, and tumorigenicity assays in vivo, were performed to explore the function of B55δ in cisplatin (cDDP) chemotherapy of HCC. Bioinformatics prediction, luciferase reporter assays, qRT-PCR, WB, and cell cycle analyses were used to reveal the regulatory relationship between microRNA-133b (miR-133b) and PPP2R2D expression. miR-133b mimic and inhibitor were used to elucidate the regulatory mechanism. Our studies showed that PPP2R2D expression was down-regulated in both HCC tumors and HCC cell lines. Treatment with cDDP increased the amount of B55δ protein. Artificially increasing the expression of B55δ counteracted cyclin-dependent kinase 1 activation, modulated transitions of the cell cycle, and increased the suppressive effect of cDDP on cell migration, colony formation, apoptosis, and proliferation in vitro and tumor growth in vivo, thus enhancing therapeutic efficiency. In contrast, knockdown of B55δ partially inhibited the effect of cDDP chemotherapy. miR-133b was shown to regulate PPP2R2D expression by binding to the 3’-untranslated region of PPP2R2D mRNA. The miR-133b/PPP2R2D signaling pathway affects the effectiveness of cDDP chemotherapy. PP2A-B55δ, regulated by miR-133b, enhances the sensitivity of HCC to cDDP chemotherapy. Our data indicate that PP2A-B55δ might be a novel and attractive target for increasing chemotherapy sensitivity of HCC.